'Shock Trump victory would lead to discounts widening'
Headlines and politics are driving healthcare. We see the outcome of the US election in a little over a week's time as a factor to guide investors within the sector - and not as a reason to avoid the sector overall.
Clinton vowed to tackle drug prices
Four funds for global themes
Latest roundup by QuotedData
The UK healthcare sector is a major beneficiary of EU R&D funding, free-movement of scientists, and a regulatory framework that expedites product approvals across the continent, writes Quilter Cheviot's Amish Patel.
Trump and Clinton fight for presidency